Qiagen (QGEN) Common Equity (2009 - 2025)

Qiagen has disclosed Common Equity across 17 years of filings, most recently posting $3.8 billion for Q4 2025.

• Common Equity for Q4 2025 came in at $3.8 billion, up 5.91% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.8 billion (up 5.91% YoY), and the FY2025 annual result was $3.8 billion, up 5.91% from the prior year.
• Common Equity came in at $3.8 billion for Q4 2025 at Qiagen, up from $3.6 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $3.8 billion in Q4 2023 to a low of $2.8 billion in Q1 2021.
• The 5-year median for Common Equity is $3.5 billion (2022), against an average of $3.4 billion.
• Across the five-year window, Common Equity gained 14.37% in 2021 and slipped 6.31% in 2024, its largest moves.
• Qiagen's Common Equity stood at $3.1 billion in 2021, then increased by 11.95% to $3.5 billion in 2022, then rose by 9.84% to $3.8 billion in 2023, then declined by 6.31% to $3.6 billion in 2024, then climbed by 5.91% to $3.8 billion in 2025.
• The last three Common Equity figures came in at $3.8 billion (Q4 2025), $3.6 billion (Q3 2025), and $3.5 billion (Q2 2025), per Business Quant data.